Clinical trial

Extension Study of Carvedilol RCT Study

NCT05021406

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-01-08

PhaseNA

Study timeline

Study start (actual)2021-01-08Date precision: day

Registry last updated2021-08-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Liver Cirrhosisunresolved

Portal Hypertensionunresolved

Interventions

Carvedilol 12.5 MGDRUG · verified · RxNorm: carvedilol 12.5 MG

Sponsors & collaborators

Beijing Friendship Hospitallead sponsor

Mapped research locations

BeijingBeijing Municipality, China6 ShanghaiShanghai Municipality, China3 TianjinTianjin Municipality, China3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05021406 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.